2.47
0.02 (0.82%)
| 前收盘价格 | 2.45 |
| 收盘价格 | 2.40 |
| 成交量 | 765,053 |
| 平均成交量 (3个月) | 1,994,303 |
| 市值 | 239,378,608 |
| 价格/销量 (P/S) | 5.75 |
| 股市价格/股市净资产 (P/B) | 1.53 |
| 52周波幅 | |
| 利润日期 | 6 Nov 2025 |
| 营业毛利率 | -259.60% |
| 营业利益率 (TTM) | -402.93% |
| 稀释每股收益 (EPS TTM) | -1.48 |
| 季度收入增长率 (YOY) | 138.20% |
| 总债务/股东权益 (D/E MRQ) | 32.99% |
| 流动比率 (MRQ) | 5.70 |
| 营业现金流 (OCF TTM) | -80.32 M |
| 杠杆自由现金流 (LFCF TTM) | -53.06 M |
| 资产报酬率 (ROA TTM) | -20.30% |
| 股东权益报酬率 (ROE TTM) | -45.55% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 混合的 |
| Biotechnology (全球的) | 混合的 | 混合的 | |
| 股票 | C4 Therapeutics, Inc. | 看涨 | 看跌 |
AIStockmoo 评分
| 分析师共识 | 5.0 |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 2.0 |
| 平均 | 1.25 |
|
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients’ lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body’s natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Value |
| 内部持股比例 | 9.79% |
| 机构持股比例 | 91.87% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 10.00 (Barclays, 304.86%) | 购买 |
| 10.00 (Wells Fargo, 304.86%) | 购买 | |
| 中 | 10.00 (304.86%) | |
| 低 | 6.00 (Stephens & Co., 142.92%) | 购买 |
| 平均值 | 8.67 (251.01%) | |
| 总计 | 3 购买 | |
| 平均价格@调整类型 | 2.60 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Barclays | 23 Sep 2025 | 10.00 (304.86%) | 购买 | 2.59 |
| 17 Sep 2025 | 8.00 (223.89%) | 购买 | 3.38 | |
| Wells Fargo | 23 Sep 2025 | 10.00 (304.86%) | 购买 | 2.59 |
| Stephens & Co. | 22 Sep 2025 | 6.00 (142.91%) | 购买 | 2.61 |
| 15 Sep 2025 | 6.00 (142.91%) | 购买 | 3.57 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合